COM:RUBIUSTX
Rubius Therapeutics
- Stock
Market Cap
5.16M
Beta: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|
net income | -11.02M - | -43.85M 298.03% | -89.19M 103.42% | -163.46M 83.26% | -167.73M 2.61% | -196.55M 17.18% | -179.67M 8.59% | |
depreciation and amortization | 118K - | 447K 278.81% | 1.26M 182.55% | 3.00M 137.13% | 5.69M 90.02% | 7.72M 35.71% | 6.25M 19.02% | |
deferred income tax | 28K - | 785K 2,703.57% | 1.86M 136.69% | -1.99M 206.84% | 266K 113.40% | 118K 55.64% | ||
stock based compensation | 147K - | 17.90M 12,078.91% | 27.53M 53.76% | 41.27M 49.92% | 33.66M 18.43% | 35.61M 5.78% | 15.78M 55.68% | |
change in working capital | 1.14M - | 2.73M 139.86% | 119K 95.64% | 10.44M 8,676.47% | 112K 98.93% | 6.69M 5,876.79% | -17.52M 361.80% | |
accounts receivables | ||||||||
inventory | ||||||||
accounts payables | 589K - | 1.11M 88.46% | 4.94M 344.86% | -1.04M 121.00% | -1.37M 32.02% | 5.86M 527.90% | -9.81M 267.48% | |
other working capital | 550K - | 1.62M 194.91% | -4.82M 397.10% | 11.48M 338.24% | 1.48M 87.10% | 836K 43.55% | -7.71M 1,022.73% | |
other non cash items | 82K - | 42K 48.78% | 86K 104.76% | 289K 236.05% | 349K 20.76% | 1.28M 266.76% | 25.01M 1,854.06% | |
net cash provided by operating activities | -9.50M - | -21.94M 130.88% | -58.34M 165.94% | -110.44M 89.31% | -127.65M 15.58% | -145.12M 13.69% | -150.14M 3.46% | |
investments in property plant and equipment | -443K - | -2.25M 408.13% | -14.95M 564.24% | -40.66M 171.92% | -5.50M 86.48% | -3.65M 33.62% | -5.30M 45.35% | |
acquisitions net | ||||||||
purchases of investments | -160.97M - | -319.13M 98.25% | -122.67M 61.56% | -83.63M - | ||||
sales maturities of investments | 64.28M - | 227.16M 253.36% | 228.60M 0.64% | 85M 62.82% | 83.93M 1.26% | |||
other investing activites | 17.94M - | |||||||
net cash used for investing activites | -443K - | -2.25M 408.13% | -111.64M 4,859.53% | -132.63M 18.81% | 100.43M 175.72% | 81.35M 19.00% | 12.94M 84.09% | |
debt repayment | -5.50M - | -75.70M - | ||||||
common stock issued | 100K - | 257.87M 257,766% | 188M - | 232K 99.88% | ||||
common stock repurchased | -122K - | |||||||
dividends paid | ||||||||
other financing activites | 15.42M - | 121.59M 688.64% | 122.46M 0.72% | 27.41M 77.62% | 26.48M 3.39% | 10.45M 60.53% | ||
net cash used provided by financing activities | 15.42M - | 121.69M 689.29% | 374.83M 208.01% | 27.29M 92.72% | 26.48M 2.96% | 198.45M 649.33% | -75.47M 138.03% | |
effect of forex changes on cash | ||||||||
net change in cash | 5.47M - | 97.50M 1,681.55% | 204.85M 110.09% | -215.79M 205.34% | -732K 99.66% | 134.68M 18,499.18% | -212.67M 257.90% | |
cash at beginning of period | 1.59M - | 7.07M 343.13% | 104.57M 1,379.51% | 309.42M 195.89% | 93.63M 69.74% | 92.90M 0.78% | 227.58M 144.97% | |
cash at end of period | 7.07M - | 104.57M 1,379.51% | 309.42M 195.89% | 93.63M 69.74% | 92.90M 0.78% | 227.58M 144.97% | 14.91M 93.45% | |
operating cash flow | -9.50M - | -21.94M 130.88% | -58.34M 165.94% | -110.44M 89.31% | -127.65M 15.58% | -145.12M 13.69% | -150.14M 3.46% | |
capital expenditure | -443K - | -2.25M 408.13% | -14.95M 564.24% | -40.66M 171.92% | -5.50M 86.48% | -3.65M 33.62% | -5.30M 45.35% | |
free cash flow | -9.95M - | -24.19M 143.23% | -73.29M 203.00% | -151.10M 106.16% | -133.15M 11.88% | -148.77M 11.74% | -155.45M 4.49% |
All numbers in (except ratios and percentages)